Transparency notification
December 18 2017 - 1:30AM
Mechelen,
Belgium; 18 December 2017; 7.30 CET; regulated information -
Galapagos NV (Euronext & NASDAQ: GLPG) received a
transparency notification from Gilead Sciences, Inc.
Pursuant to Belgian transparency
legislation[1], Galapagos
received a transparency notification on 13 December 2017 from
Gilead Sciences, Inc., who notified that its subsidiary Gilead
Biopharmaceutics Ireland UC transferred its holding of 6,760,701
Galapagos shares on 7 December 2017 to its subsidiary
Gilead Therapeutics A1 Unlimited Company. This shareholding
represents 13.27% of Galapagos' currently outstanding 50,936,778
shares, and represents no change in the number of shares compared
to the previous transparency notification from Gilead Sciences Inc.
on 20 January 2016. The full transparency notice is available on
the Galapagos website.
About Galapagos
Galapagos (Euronext & NASDAQ: GLPG) is a clinical-stage
biotechnology company specialized in the discovery and development
of small molecule medicines with novel modes of action. Galapagos'
pipeline comprises Phase 3 through to discovery programs in cystic
fibrosis, inflammation, fibrosis, osteoarthritis and other
indications. Our target discovery platform has delivered three
novel mechanisms showing promising patient results in,
respectively, inflammatory diseases, idiopathic fibrosis and atopic
dermatitis. Galapagos is focused on the development and
commercialization of novel medicines that will improve people's
lives. The Galapagos group, including fee-for-service subsidiary
Fidelta, has approximately 578 employees, operating from its
Mechelen, Belgium headquarters and facilities in the Netherlands,
France, and Croatia. More information at www.glpg.com.
Contact
Investors:
Elizabeth Goodwin
VP IR & Corporate Communications
+1 781 460 1784
Paul van der Horst
Director IR & Business Development
+31 71 750 6707
ir@glpg.com
Media:
Evelyn Fox
Director Communications
+31 6 53 591 999
communications@glpg.com
[1]
Belgian Act of 2 May 2007 on the disclosure of
major shareholdings in issuers whose shares are admitted to trading
on a regulated market.
Transparency GILD
This
announcement is distributed by Nasdaq Corporate Solutions on behalf
of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely
responsible for the content, accuracy and originality of the
information contained therein.
Source: Galapagos NV via Globenewswire
Galapagos NV (NASDAQ:GLPG)
Historical Stock Chart
From Mar 2024 to Apr 2024
Galapagos NV (NASDAQ:GLPG)
Historical Stock Chart
From Apr 2023 to Apr 2024